Researchers have shown that an engineered antibody called DTA-1 led to rejection of 50 to 60 percent of tumors in a mouse model of melanoma. The antibody allows the immune system to overcome its natural reluctance to attack tumor cells, the researchers say, and might serve to boost the effectiveness of cancer vaccines.
Full article >>
Monday, April 27, 2009
How An Antibody Helps The Immune System Reject Cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment